We are live on ! Find out more
Wolverine Trading

Wolverine Trading Portfolio holdings

AUM $139B
1-Year Est. Return 31.83%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+31.83%
3 Year Est. Return
+143.85%
5 Year Est. Return
+179.05%
10 Year Est. Return
AUM
$21.8B
AUM Growth
+$3.61B
Cap. Flow
+$3.01B
Cap. Flow %
13.83%
Top 10 Hldgs %
18.11%
Holding
5,525
New
1,399
Increased
1,367
Reduced
1,397
Closed
1,345

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.91%
2 Communication Services 1.69%
3 Technology 1.67%
4 Financials 0.69%
5 Consumer Staples 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGB icon
3951
PUT
Gerdau
GGB
$9.72B
$81K ﹤0.01%
33,768
+19,908
+144% +$47K
MTW icon
3952
Manitowoc
MTW
$527M
$81K ﹤0.01%
3,463
-291
-8% -$6.81K
VNET
3953
PUT
VNET Group
VNET
$1.92B
$81K ﹤0.01%
+16,000
New +$86.7K
TCS
3954
PUT
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$81K ﹤0.01%
920
-533
-37% -$38.3K
CORV
3955
PUT
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$81K ﹤0.01%
19,300
+4,000
+26% +$14.5K
CERS icon
3956
CALL
Cerus
CERS
$585M
$80K ﹤0.01%
32,200
+20,300
+171% +$65K
CLMT icon
3957
PUT
Calumet Specialty Products
CLMT
$3.61B
$80K ﹤0.01%
19,100
+4,300
+29% +$17.2K
HLIT icon
3958
PUT
Harmonic Inc
HLIT
$1.2B
$80K ﹤0.01%
+15,100
New +$81.2K
LQDT icon
3959
PUT
Liquidity Services
LQDT
$1.23B
$80K ﹤0.01%
+12,800
New +$89.1K
RIGL icon
3960
CALL
Rigel Pharmaceuticals
RIGL
$712M
$80K ﹤0.01%
+2,850
New +$78K
CALX icon
3961
CALL
Calix
CALX
$2.34B
$79K ﹤0.01%
+11,600
New +$78.6K
FSM icon
3962
Fortuna Silver Mines
FSM
$2.55B
$79K ﹤0.01%
16,175
-20,885
-56% -$100K
SPPI
3963
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$79K ﹤0.01%
+10,700
New +$69.9K
MR
3964
PUT
DELISTED
Montage Resources Corporation Common Stock
MR
$79K ﹤0.01%
1,773
-640
-27% -$22.4K
FRO icon
3965
Frontline
FRO
$8.63B
$78K ﹤0.01%
+13,965
New +$85.8K
XXII
3966
22nd Century Group
XXII
$1.36M
0
CCEC
3967
Capital Clean Energy Carriers
CCEC
$1.36B
$78K ﹤0.01%
3,268
-1,575
-33% -$37.6K
LUMO
3968
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$78K ﹤0.01%
+1,178
New +$146K
EXPR
3969
DELISTED
Express, Inc.
EXPR
$78K ﹤0.01%
575
-949
-62% -$147K
ATRS
3970
DELISTED
Antares Pharma, Inc.
ATRS
$78K ﹤0.01%
24,064
-1,214
-5% -$3.44K
ACHN
3971
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$78K ﹤0.01%
17,300
+1,200
+7% +$4.82K
SEAC
3972
PUT
DELISTED
Seachange International Inc
SEAC
$77K ﹤0.01%
1,425
+875
+159% +$44.4K
MITL
3973
PUT
DELISTED
Mitel Networks Corporation
MITL
$77K ﹤0.01%
10,700
+400
+4% +$2.79K
EGLE
3974
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$77K ﹤0.01%
+2,283
New +$77.6K
AHT
3975
CALL
Ashford Hospitality Trust
AHT
$20.9M
$76K ﹤0.01%
+12
New +$75K

Similar funds

Wolverine Trading's Q2 2017 Portfolio in Review

As of Q2 2017, Wolverine Trading held 5,525 positions worth $21.8B, up 20% from $18.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Wolverine Trading deployed $3.01B of net new capital in Q2 2017, opening 1,399 new positions and adding to 1,367 existing holdings. Its largest new stake was Tesla: 2,094,870 shares worth $50.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.2% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $40.7M trimmed.

  • Wolverine Trading's largest Q2 2017 buy was Tesla: 2,094,870 shares worth $50.4M.
  • Wolverine Trading added most to State Street SPDR S&P 500 ETF Trust in Q2 2017, an estimated $156M increase.
  • Wolverine Trading's biggest Q2 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $40.7M.
  • Wolverine Trading fully exited Vanguard Short-Term Corporate Bond ETF in Q2 2017, selling an estimated $8.09M.
  • Wolverine Trading's ten largest holdings make up 18% of its $21.8B portfolio in Q2 2017.
  • Wolverine Trading opened 1,399 new positions and closed 1,345 in Q2 2017.
  • Wolverine Trading's portfolio value rose 20% quarter-over-quarter to $21.8B.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.